Curis

$11.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.33 (-2.79%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Curis and other stocks, options, and ETFs commission-free!

About CRIS

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327.

CEO
James E. Dentzer
Employees
28
Headquarters
Lexington, Massachusetts
Founded
2000
Market Cap
1.04B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.87M
High Today
$11.87
Low Today
$11.38
Open Price
$11.86
Volume
1.16M
52 Week High
$13.44
52 Week Low
$0.6699

CRIS Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, After Hours

You May Also Like

EXFO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure